Scarica l'app Stockscreener
49.95
3.94%
-2.05
Pre-mercato:
49.50
-0.45
-0.90%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Soleno Therapeutics Inc Borsa (SLNO) Ultime notizie
Soleno Therapeutics (SLNO) Valuation Check After Wolfe Research’s Optimistic New Coverage and Stock Pop - Yahoo Finance
How Soleno Therapeutics' Audit Committee Leadership Transition At Soleno Therapeutics (SLNO) Has Changed Its Investment Story - Yahoo Finance
34,840 Shares in Soleno Therapeutics, Inc. $SLNO Purchased by Castleark Management LLC - MarketBeat
Soleno Therapeutics Gains Momentum Following Wolfe Research Favorable Rating - timothysykes.com
Soleno Therapeutics, Inc. $SLNO Shares Sold by Holocene Advisors LP - MarketBeat
Soleno Therapeutics Stock Poised for Growth as Wolfe Research Issues Positive Rating - StocksToTrade
Soleno Therapeutics Rises as Wolfe Research Gives Positive Outlook - timothysykes.com
Adage Capital Partners GP L.L.C. Decreases Position in Soleno Therapeutics, Inc. $SLNO - MarketBeat
Valuation Update: Will Soleno Therapeutics Inc. stock recover faster than peersJuly 2025 Pullbacks & AI Powered Market Entry Ideas - moha.gov.vn
Soleno Therapeutics (SLNO) Reports Strong Q3 Earnings Despite VYKAT XR Safety Concerns - MSN
Technical Reactions to SLNO Trends in Macro Strategies - news.stocktradersdaily.com
Soleno Therapeutics (NASDAQ:SLNO) Shares Gap UpStill a Buy? - MarketBeat
Rhythm Pharma Strikes Chord As Early PWS Trial Results Show Promise - Benzinga
Is Soleno Therapeutics, Inc. (SLNO) The Cheap Healthcare Stock To Buy Heading Into 2026? - Insider Monkey
Gainers Report: What insider trading reveals about Soleno Therapeutics Inc stockOil Prices & High Return Trade Guides - moha.gov.vn
Diadema Partners LP Has $23.81 Million Stock Position in Soleno Therapeutics, Inc. $SLNO - MarketBeat
Soleno Therapeutics, Inc. $SLNO Stake Reduced by Vivo Capital LLC - MarketBeat
Marshall Wace LLP Purchases 164,580 Shares of Soleno Therapeutics, Inc. $SLNO - MarketBeat
Aug Movers: How buybacks impact Soleno Therapeutics Inc stock valueJuly 2025 Big Picture & Real-Time Buy Signal Notifications - moha.gov.vn
Soleno Therapeutics (NASDAQ:SLNO) Nasdaq Index Clinical Pipeline Growth - Kalkine Media
Soleno Therapeutics, Inc. (NASDAQ:SLNO) Receives Consensus Recommendation of "Buy" from Analysts - MarketBeat
Russell Investments Group Ltd. Acquires 82,932 Shares of Soleno Therapeutics, Inc. $SLNO - MarketBeat
Rhumbline Advisers Acquires 22,607 Shares of Soleno Therapeutics, Inc. $SLNO - MarketBeat
Johnson Fistel Begins Investigation on Behalf of Soleno Therapeutics, Inc. (SLNO) Shareholders Who Have Incurred Losses - The Malaysian Reserve
Johnson Fistel Begins Investigation on Behalf of Soleno Therapeu - GuruFocus
Soleno Therapeutics board member William Harris passes away By Investing.com - Investing.com Canada
Will Soleno Therapeutics Inc. stock deliver shareholder valueJuly 2025 Short Interest & Verified High Yield Trade Plans - Newser
Why Soleno Therapeutics Inc. (6XC) stock remains stableEarnings Summary Report & High Accuracy Buy Signal Tips - Newser
Is Soleno Therapeutics Inc. stock in correction or buying zoneEarnings Growth Summary & Technical Pattern Based Buy Signals - Newser
Soleno Turns First Profit on $66 Million in Revenue — Is This Why One Investor Just Made an $87 Million Bet? - Nasdaq
Bragar Eagel & Squire, P.C. Encourages Agilon, Soleno, Avita, and Coty Investors to Contact ... - Enidnews.com
Bragar Eagel & Squire, P.C. Encourages Agilon, Soleno, - GlobeNewswire
Soleno Therapeutics board member William Harris passes away - Investing.com
Soleno Therapeutics Announces the Passing of Board Member William G. Harris - The Manila Times
Soleno Therapeutics, Inc. Announces Demise of William G. Harris, Member of Board of Directors and Audit Committee Changes - marketscreener.com
Why Soleno Therapeutics Inc. (6XC) stock is a strong analyst pickMarket Weekly Review & Step-by-Step Trade Execution Guides - Newser
Wolfe Research Initiates Soleno Therapeutics (SLNO) Coverage with Outperform Rating, $75 PT, Dismisses Patient Slowdown Concerns - MSN
How buybacks impact Soleno Therapeutics Inc. stock valueJuly 2025 Closing Moves & Weekly Chart Analysis and Guides - Newser
How Does Wolfe Research’s Support Shape Soleno Therapeutics’ (SLNO) Credibility Amid Heightened Scrutiny? - simplywall.st
Johnson Fistel Begins Investigation on Behalf of Soleno - GlobeNewswire
Soleno Therapeutics, Inc. (SLNO) Investigation: Bronstein, Gewirt - The National Law Review
Soleno Therapeutics (SLNO): Does Current Valuation Signal Opportunity or Caution for Investors? - Yahoo Finance
Trading the Move, Not the Narrative: (SLNO) Edition - news.stocktradersdaily.com
Could Soleno Therapeutics Have Room to Run After FDA Designation Sparks 11.8% Rally? - Yahoo Finance
ROSEN, NATIONALLY RECOGNIZED INVESTOR COUNSEL, Encourages Soleno - The National Law Review
Handelsbanken Fonder AB Acquires Shares of 10,400 Soleno Therapeutics, Inc. $SLNO - MarketBeat
Soleno Therapeutics, Inc. $SLNO Shares Sold by F m Investments LLC - MarketBeat
Franklin Resources Inc. Buys New Shares in Soleno Therapeutics, Inc. $SLNO - MarketBeat
12 Best Upside Stocks to Buy Now - Insider Monkey
Analyst Dismisses ViCAT XR Safety Fears, Expects Strong Growth Despite Recent Stock Weakness - Finviz
Market Recap: Will Soleno Therapeutics Inc. stock recover faster than peers2025 Top Gainers & Precise Entry and Exit Recommendations - BỘ NỘI VỤ
0.36%
1.05%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):